Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?
Amedeo Lonardo, Christopher D. Byrne, Giovanni Targher
Metabolism and Target Organ Damage (2021)
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Emerging role of aging in the progression of NAFLD to HCC
Yongyuan He, Yinghong Su, Chengcheng Duan, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101833-101833
Closed Access | Times Cited: 45
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
Amedeo Lonardo, Ashwani K. Singal, Natalia A. Osna, et al.
Metabolism and Target Organ Damage (2022) Vol. 2, pp. 12-12
Open Access | Times Cited: 41
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, et al.
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 27
Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease
A‐Na Liu, Cuifang Xu, Ya‐Ru Liu, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 8, pp. 872-885
Open Access | Times Cited: 20
Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
Sara Piccini, Giuseppe Favacchio, Emanuela Morenghi, et al.
Diabetes Research and Clinical Practice (2024) Vol. 212, pp. 111689-111689
Open Access | Times Cited: 5
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Díaz, Juan Pablo Arab, Francisco Idalsoaga, et al.
Annals of Hepatology (2025), pp. 101903-101903
Open Access
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers
Amedeo Lonardo
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 891-911
Closed Access | Times Cited: 12
Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk
Amedeo Lonardo, Gjin Ndrepepa
Metabolism and Target Organ Damage (2022) Vol. 2, Iss. 4, pp. 17-17
Open Access | Times Cited: 18
Liver stiffness as a cornerstone in heart disease risk assessment
Joost Boeckmans, Laurent Sandrin, Christian Knackstedt, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 344-356
Open Access | Times Cited: 9
Gut Microbes, Diet, and Genetics as Drivers of Metabolic Liver Disease: A Narrative Review Outlining Implications for Precision Medicine
Jake B. Hermanson, Samar A. Tolba, Evan A. Chrisler, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 133, pp. 109704-109704
Closed Access | Times Cited: 3
Towards Multiplexed and Multimodal Biosensor Platforms in Real-Time Monitoring of Metabolic Disorders
Yong-Ho Chung, Hung Anh Nguyen, Jimmy Zhang, et al.
Sensors (2022) Vol. 22, Iss. 14, pp. 5200-5200
Open Access | Times Cited: 13
Precision medicine in nonalcoholic fatty liver disease
Amedeo Lonardo
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 7, pp. 1175-1178
Open Access | Times Cited: 12
Sex- and gender-differences in chronic long-term complications of type 1 and type 2 diabetes mellitus in Italy
Giuseppina Russo, Valeria Manicardi, Maria Cecilia Rossi, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 10, pp. 2297-2309
Open Access | Times Cited: 12
Extra-hepatic cancers in metabolic fatty liver syndromes
Amedeo Lonardo
(2023), pp. 11-17
Open Access | Times Cited: 6
Evaluation of metabolic changes in clinic attendees with therapeutic carbohydrate restriction
Kirsty Woods, Hilmi Sulaiman Rathomi, Thomas L. Smith, et al.
Journal of Metabolic Health (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)
Fernando Bril
EBioMedicine (2021) Vol. 72, pp. 103584-103584
Open Access | Times Cited: 10
Adiposity, hepatic steatosis, and metabolic health transitions in people with obesity: Influences of age and sex
Alvaro M. Netto, Nea Miwa Kashiwagi, Carlos André Minanni, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 6, pp. 1149-1157
Closed Access | Times Cited: 3
Metabolic‐associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
Jiwon Chang, Yoosoo Chang, Yoosun Cho, et al.
Liver International (2023) Vol. 43, Iss. 11, pp. 2548-2559
Open Access | Times Cited: 3
Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study
Goh Eun Chung, Kyungdo Han, Kyu‐na Lee, et al.
Diabetes & Metabolism (2023) Vol. 49, Iss. 4, pp. 101454-101454
Closed Access | Times Cited: 3
The sulfur microbial diet and risk of nonalcoholic fatty liver disease: a prospective gene–diet study from the UK Biobank
Zhening Liu, Hangkai Huang, Jiaqi Ruan, et al.
American Journal of Clinical Nutrition (2023) Vol. 119, Iss. 2, pp. 417-424
Closed Access | Times Cited: 2
Relationship between the consumption of wholegrain and nonalcoholic fatty liver disease: The TCLSIH cohort study
Hanzhang Wu, Xiaolu He, Qian Li, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 7, pp. 1483-1490
Closed Access | Times Cited: 4
Separating the apples from the oranges: from NAFLD heterogeneity to personalized medicine
Amedeo Lonardo
Exploration of Medicine (2021)
Open Access | Times Cited: 5
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics
Amedeo Lonardo, Ralf Weiskirchen
Metabolites (2024) Vol. 14, Iss. 8, pp. 408-408
Open Access
Editorial - Reflecting on three years of M&TOD - Where we are and where we are going
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 3
Open Access
SARS-CoV2 Infection and Comorbidities, Role in Oncogenesis
Л. В. Спирина, Nadezhda Masunova, Vladimir Masunov, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 7, pp. 2191-2197
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top